Pembrolizumab Plus Chemotherapy for HR+/HER2− PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study

Annals of Oncology · Elsevier

Аннотация

Publication date: Available online 24 October 2026 Source: Annals of Oncology Author(s): H.S. Rugo, M. Kok, A. Goncalves, D. Loirat, G. Bianchini, P.A. Fasching, D.W. Cescon, R. Romero Díaz, F. Zagouri, E. Korbenfeld, F. Dalenc, Y. Jerez Gilarranz, J. Hashimoto, Y.H. Park, S.-A. Im, X. Hu, K.M. Hirshfield, L. Jia, K. Tryfonidis, P. Schmid

Читать у издателя →

Похожие статьи